Charles S. Berkman, SVP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 36,194 shares at $178.50 ($6.5M) on 2021-02-04, disclosed to the SEC on 2021-02-05.
Seasonal sale ($6.5M) by SVP, General Counsel & Secretary — this insider has traded LGND in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $178.50 | 18,097 | $3.2M | 50.0% |
| 2 | $178.50 | 18,097 | $3.2M | 50.0% |
| Total | $178.50 avg | 36,194 | $6.5M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |